Mutations

U.S. FDA gearing up for rapid review of potential COVID-19 booster shots

Fri, 2021-02-05 09:55 — mike kraft

U.S. FDA gearing up for rapid review of potential COVID-19 booster shots The U.S. Food and Drug Administration is planning a rapid review process for quick turnaround of new COVID-19 booster shots if variants of the coronavirus emerge against which the vaccines do not provide protection, the agency's top official said on Thursday. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA gearing up for rapid review of potential COVID-19 booster shots
Log in or register to post comments

Biden health team hatches new vaccine strategy as variant threat builds

Thu, 2021-02-04 19:04 — mike kraft

Biden health team hatches new vaccine strategy as variant threat builds The agency's acting director, Janet Woodcock, said in a statement Thursday that the agency would release updates soon. POLITICO

The Food and Drug Administration is preparing to release new standards for Covid-19 vaccine booster shots, tests and drugs in the coming weeks — all aimed at preparing the country to beat back fast-spreading virus variants that are less susceptible to existing shots.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Biden health team hatches new vaccine strategy as variant threat builds
Log in or register to post comments

Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples

Wed, 2021-02-03 10:26 — mike kraft

Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples In experiments and clinical trials, mutation appears to limit the effectiveness of vaccines. Joel Achenbach, William Booth Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Worrisome coronavirus mutation seen in U.K. variant and in some U.S. samples
Log in or register to post comments

Oxford finds COVID-19 shot 76% effective for 3 months after single dose

Tue, 2021-02-02 14:18 — mike kraft

Oxford finds COVID-19 shot 76% effective for 3 months after single dose Oxford University and AstraZeneca's COVID-19 vaccine showed in a study it had 76% efficacy against symptomatic infection for three months after a single dose, which increased if the second shot is delayed, backing Britain's vaccine rollout policy. Alistair Smout U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Oxford finds COVID-19 shot 76% effective for 3 months after single dose
Log in or register to post comments

Small study suggests Pfizer's COVID-19 vaccine less effective against South African variant

Tue, 2021-02-02 14:07 — mike kraft

Study suggests Pfizer's COVID-19 vaccine less effective against South African variant The Pfizer-BioNTech COVID-19 vaccine may be less able to protect against infection with a South African variant of the virus that has a worrying mutation, according to results of a British study released on Tuesday. Kate Kelland U.S.

LONDON (Reuters) - The Pfizer-BioNTech COVID-19 vaccine may be less able to protect against infection with a South African variant of the virus that has a worrying mutation, according to results of a British study released on Tuesday.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Small study suggests Pfizer's COVID-19 vaccine less effective against South African variant
Log in or register to post comments

Biden administration to keep following two-dose schedule for Covid-19 vaccines

Mon, 2021-02-01 14:01 — mike kraft

Biden administration to keep following two-dose schedule for Covid-19 vaccines It is still recommended for people to get their second dose of Covid-19 vaccine on time, Dr. Rochelle Walensky, director of the US Centers for Disease Control and Prevention, said during a White House briefing on Monday. By Nectar Gan, Adam Renton and Kara Fox, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Biden administration to keep following two-dose schedule for Covid-19 vaccines
Log in or register to post comments

PANEL DISCUSSION: Monday 2PM EST -The swift global emergence of SARS-CoV-2 variants and their impact on both the domestic and global Covid-19 response.

Sun, 2021-01-31 15:38 — mike kraft

Cause for Concern?

Monday, February 1, 2021 2:00 pm - 3:00 pm

Add to Calendar

Meeting / Event Tags:

Roundtable

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Other

Why America is ‘flying blind’ to the coronavirus mutations racing across the globe

Sat, 2021-01-30 13:54 — mike kraft

Why America is ‘flying blind’ to the coronavirus mutations racing across the globe America currently has so little of the genetic sequencing needed to detect mutated versions of coronavirus - like those first discovered in Britain and South Africa - that such variants are likely proliferating quickly, undetected. William Wan, Ben Guarino Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Why America is ‘flying blind’ to the coronavirus mutations racing across the globe
Log in or register to post comments

Johnson & Johnson vaccine 66 percent effective, drops against South Africa variant

Fri, 2021-01-29 09:40 — mike kraft

Johnson & Johnson vaccine 66 percent effective, drops against South A COVID-19 single-shot vaccine from Johnson & Johnson was 66 percent effective in preventing moderate or severe disease in a Phase 3 clinical trial, a level of protection above the Food and Drug Peter Sullivan TheHill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Johnson & Johnson vaccine 66 percent effective, drops against South Africa variant
Log in or register to post comments

Novavax COVID-19 vaccine works, but less so against variants

Thu, 2021-01-28 19:52 — mike kraft

Novavax COVID-19 vaccine works, but less so against variants Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated... AP NEWS

Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not as well — against new mutated versions of the virus circulating in that country and South Africa.

Country / Region Tags:

General Topic Tags: